Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice

European Journal of Pharmacology

Volumn 534, Issue 1-3, 2006, Pages 194-201

  Wang, Huiping ^a   Li, Yan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Acute hepatic failure; Bicyclol; D galactosamine; Lipopolysaccharide

Indexed keywords

AMINOTRANSFERASE; BENZENE DERIVATIVE; BICYCLOL; BILIRUBIN; CD14 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; DEXAMETHASONE; GALACTOSAMINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HISTOPATHOLOGY; LIVER FAILURE; LIVER PROTECTION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD14; BIPHENYL COMPOUNDS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GALACTOSAMINE; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED ICR; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644894450     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.080     Document Type: Article

References (33)

1. Y. Batra, and S.K. Acharya Acute liver failure: prognostic markers Indian. J. Gastroenterol. 22 Suppl 2 2003 S66 S68
2. B. Beutler, I.W. Milsark, and A.C. Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869 871
3. B. Beutler, X. Du, and A. Poltorak Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies J. Endotoxin Res. 7 2001 277 280
4. C.A. Bradham, J. Plumpe, M.P. Manns, D.A. Brenner, and C. Trautwein Mechanisms of hepatic toxicity. I. TNF-induced liver injury Am. J. Physiol. 275 1998 G387 G392
5. B.D. Car, V.M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffer Interferon gamma receptor deficient mice are resistant to endotoxic shock J. Exp. Med. 179 1994 1437 1444
6. J. da Silva Correia, K. Soldau, U. Christen, P.S. Tobias, and R.J. Ulevitch Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2 J. Biol. Chem. 276 2001 21129 21135
7. M. Emoto, Y. Emoto, V. Brinkmann, M. Miyamoto, I. Yoshizawa, M. Staber, N. Rooijen, A. Hamann, and S. Kaufmann Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-alpha and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance J. Immunol. 171 2003 584 593
8. N.A. Essani, M.A. Fisher, A. Farhood, A.M. Manning, C.W. Smith, and H. Jaeschke Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure Hepatology 21 1995 1632 1639
9. E. Ferrero, D. Jiao, B.Z. Tsuberi, L. Tesio, G.W. Rong, A. Haziot, and S.M. Goyert Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide Proc. Natl. Acad. Sci. U. S. A. 90 1993 2380 2384
10. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc. Natl. Acad. Sci. U. S. A. 76 1979 5939 5943
11. G. Grutz New insights into the molecular mechanism of interleukin-10-mediated immunosuppression J. Leukoc. Biol. 77 2005 3 15
12. A. Haziot, E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C.L. Stewart, and S.M. Goyert Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice Immunity 4 1996 407 414
13. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akria Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product J. Immunol. 162 1999 3749 3752
14. M. Howard, T. Muchamuel, S. Andrade, and S. Menon Interleukin 10 protects mice from lethal endotoxemia J. Exp. Med. 177 1993 1205 1208
15. S. Jiang, M. Naito, C. Kaizu, K. Kuwata, G. Hasegawa, N. Mukaida, and L.D. Shultz Lipopolysaccharide-induced cytokine and receptor expression and neutrophil infiltration in the liver of osteopetrosis (op/op) mutant mice Liver 20 2000 465 474
16. W.M. Lee Acute liver failure N. Engl. J. Med. 329 1993 1862 1872
17. WM. Lee Acute liver failure Am. J. Med. 96 1994 3S 9S
18. W. Lesslauer, H. Tabuchi, R. Gentz, M. Brockhaus, E.J. Schlaeger, G. Grau, P.F. Piguet, P. Pointaire, P. Vassalli, and H. Loetscher Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality Eur. J. Immunol. 21 1991 2883 2886
19. Y. Li, Y. Li, and G.T. Liu Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride Chin. Med. J. 84 2004 2096 2101
20. G.T. Liu The anti-virus and hepatoprotective effect of bicyclol and its mechanism of action Chin. J. New Drug 10 2001 325 327
21. T. Liu, T. Matsuguchi, N. Tsuboi, Y. Yajima, and Y. Yoshikai Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice Infect. Immun. 70 2002 6638 6645
22. H. Louis, O. Le Moine, M.O. Peny, B. Gulbis, F. Nisol, M. Goldman, and J. Deviere Hepatoprotective role of interleukin 10 in galactosamine/ lipopolysaccharide mouse liver injury Gastroenterology 112 1997 935 942
23. K. Matsuura, T. Ishida, M. Setoguchi, M. Higuchi, S. Akizuki, and S. Yamamoto Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide J. Exp. Med. 179 1994 1671 1676
24. H. Mizuhara, E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 J. Exp. Med. 179 1994 1529 1537
25. M. Nagaki, M. Tanaka, A. Sugiyama, H. Ohnishi, and H. Moriwaki Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice J. Hepatol. 31 1999 815 824
26. T. Nakama, S. Hirono, A. Moriuchi, S. Hasuike, K. Nagata, T. Hori, A. Ido, K. Hayashi, and H. Tsubouchi Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality Hepatology 33 2001 1441 1450
27. H. Oku, H. Nakazato, T. Horikawa, Y. Tsuruta, and R. Suzuki Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock Eur. J. Pharmacol. 446 2002 167 176
28. E.M. Palsson-McDermott, and L.A. O'Neill Signal transduction by the lipopolysaccharide receptor Toll-like receptor-4 Immunology 113 2001 153 162
29. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, Huffel C. Van, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
30. F.V. Schiodt, and W.M. Lee Fulminant liver disease Clin. Liver Dis. 7 2003 331 349 (vi)
31. G. Tiegs, M. Wolter, and A. Wendel Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice Biochem. Pharmacol. 38 1989 627 631
32. K.J. Tracey, Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Cerami Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662 664
33. G.B. Yao, D.Zh. Xu, P. Lan, Ch.B. Xu, Ch. Wang, J. Luo, Y.M. Shen, and Q. Li Efficacy and safety of bicyclol in treatment of 2,200 chronic viral hepatitis Chin. J. New. Drugs. Clin. Rem. 24 2005 421 426